Click here for COVID-19 updates and information.

Maxor 340B sponsored a new report about the state of Community Health Centers! Download now.

Category: Maxor Specialty

Cystic Fibrosis Awareness Month - treating CF

Treating Cystic Fibrosis

Blog, Maxor, Maxor Specialty

CF CF awareness CF awareness month Cystic Fibrosis rare diseases

Rare Disease Day

Rare Disease Day 2022

Blog, Maxor, Maxor Specialty

CF Cystic Fibrosis rare disease day rare diseases

Watch Part 1 of our webinar series, Specialty Pipeline Trends

Maxor Webinar, “Specialty Pipeline Trends” by Sarah Richards and Jessie Heaton Available Now

Maxor, Maxor Specialty, MaxorPlus

Specialty Specialty Drug Pipeline

Image with "Specialty Updates" text

Winter Weather Update – 2/16/2021

Maxor Specialty

Cystic Fibrosis Maxor Specialty Pharmacy

Photo of Michael Einodshofer, RPh, MBA, Chief Pharmacy Officer

Maxor Chief Pharmacy Officer, Michael Einodshofer, officially becomes Chairman of the Board during NASP 2020

Industry News, Maxor, Maxor Specialty, MaxorPlus, Press Releases

Einodshofer Maxor Maxor Specialty Pharmacy NASP Specialty

Photos of people in various activities, with the words "Maxor Specialty Pharmacy - Improving outcomes every day"

We improve outcomes every day

Maxor, Maxor Specialty

Cystic Fibrosis Maxor Specialty Pharmacy

Screenshot of the Maxor webinar with the title "Specialty Pipeline and Management Solutions"

MaxorPlus Webinar – Specialty Pipeline and Management Solutions Available

Clinical News, Maxor, Maxor Specialty, MaxorPlus

HIV Pipeline Specialty

Maxor Announces Rebranding Of Maxor Specialty Pharmacy

Maxor Specialty, Press Releases

Maxor’s Response to the Coronavirus

Clinical News, COVID-19, Maxor Pharmacy Management, Maxor Specialty, Maxor340B, MaxorPlus

Neurelis announces commercial availability of Valtoco® (Diazepam nasal spray) for seizure cluster rescue

Industry News, Maxor Specialty, Press Releases